Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPF and UVA Protection Assay of BAY987517
NCT02995135Completed
- Sponsor
- Bayer
- Start
- Jan 2017
- Primary completion
- Jan 2017
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of BAY987517 in sunburn, sponsored by Bayer. Primary endpoints: Minimal Erythema Dose up to 15 minutes and Minimal Persistent Pigment Darkening Dose up to 15 minutes. Started Jan 2017; status: completed.
02
Drugs
BAY987517
03
Conditions
sunburn
Beyond the preview
Go deeper on NCT02995135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02995135.